يعرض 1 - 10 نتائج من 71 نتيجة بحث عن '"Saoudi Gonzalez, Nadia"', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Ros J, Baraibar I, Saoudi González N, Rodríguez-Castells M, García A, Alcaraz A, Salva F, Tabernero J, Elez E Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vaghi C Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Department of Hematology, Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: International Journal of Molecular Sciences;25(6); https://doi.org/10.3390/ijms25063304Test; Ros J, Vaghi C, Baraibar I, Saoudi González N, Rodríguez-Castells M, García A, et al. Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver. Int J Mol Sci. 2024 Mar 14;25(6):3304.; https://hdl.handle.net/11351/11281Test

  2. 2
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Saoudi González N, Ros J, Baraibar I, Salvà F, Rodríguez-Castells M, Alcaraz A, Tabernero J, Élez E Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. García A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cancers;16(2); https://doi.org/10.3390/cancers16020412Test; Saoudi González N, Ros J, Baraibar I, Salvà F, Rodríguez-Castells M, Alcaraz A, et al. Cetuximab as a Key Partner in Personalized Targeted Therapy for Metastatic Colorectal Cancer. Cancers (Basel). 2024 Jan;16(2):412.; https://hdl.handle.net/11351/11057Test; 001151894500001

  3. 3
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Rodriguez Castells M, Baraibar I, Ros J, Saoudi N, Tabernero J, Élez E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Salvà F Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. García A, Alcaraz A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Frontiers in Oncology;13; https://doi.org/10.3389/fonc.2023.1272561Test; Rodriguez Castells M, Baraibar I, Ros J, Saoudi N, Salvà F, García A, et al. The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey. Front Oncol. 2023 Oct 16;13:1272561.; https://hdl.handle.net/11351/10611Test

  4. 4
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Ros J Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Matito J, Comas R, Garcia A, Toledo R, Dientsmann R, Vivancos A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Villacampa G Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. The Institute of Cancer Research, London, UK. Martini G Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. Baraibar I, Saoudi N, Salvà F, Tabernero J, Elez E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Martin Á Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Annals of Oncology;34(6); https://doi.org/10.1016/j.annonc.2023.02.016Test; info:eu-repo/grantAgreement/ES/PE2017-2020/PI20%2F00968; Ros J, Matito J, Villacampa G, Comas R, Garcia A, Martini G, et al. Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments. Ann Oncol. 2023 Jun;34(6):543–52.; https://hdl.handle.net/11351/9929Test

  5. 5
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Hernando-Calvo A Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Vila-Casadesús M, Gonzalez-Medina A, Lo Giacco D, Martin A, Fasani R, Mancuso F, Berche R, Jimenez J, Dienstmann R, Nuciforo P, Seoane J, Vivancos A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Bareche Y Institut du Cancer de Montréal, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada. Abbas-Aghababazadeh F Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Saavedra O, Brana I, Vieito M, Mirallas O, Saoudi Gonzalez N, Valverde C, Muñoz-Couselo E, Suarez C, Diez M, Élez E, Capdevila J, Oaknin A, Saura C, Macarulla T, Carles Galceran J, Felip E, Tabernero J, Garralda E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Med;4(10); https://doi.org/10.1016/j.medj.2023.07.006Test; Hernando-Calvo A, Vila-Casadesús M, Bareche Y, Gonzalez-Medina A, Abbas-Aghababazadeh F, Lo Giacco D, et al. A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials. Med. 2023 Oct 13;4(10):710-727.e5.; https://hdl.handle.net/11351/10525Test

  6. 6
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Saoudi González N, Salvà F, Ros J, Baraibar I, Rodríguez-Castells M, Alcaráz A, Tabernero J, Elez E Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. García A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vega S, Bueno S Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Cancers;15(16); https://doi.org/10.3390/cancers15164020Test; Saoudi González N, Salvà F, Ros J, Baraibar I, Rodríguez-Castells M, García A, et al. Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications. Cancers. 2023 Aug 8;15(16):4020.; https://hdl.handle.net/11351/10212Test

  7. 7
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Linares J Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. Department of Medical Oncology, Catalan Institute of Oncology (ICO), Barcelona, Spain. Sallent-Aragay A, Badia-Ramentol J, Recort-Bascuas A, Manero-Rupérez N Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. Méndez A Department of Physics, Faculty of Science, University of Oviedo, Oviedo, Spain. Saoudi N, Elez E Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Tabernero J Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Nature Communications;14; https://doi.org/10.1038/s41467-023-36334-1Test; Linares J, Sallent-Aragay A, Badia-Ramentol J, Recort-Bascuas A, Méndez A, Manero-Rupérez N, et al. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nat Commun. 2023 Feb 10;14:746.; https://hdl.handle.net/11351/10040Test

  8. 8
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Baraibar I, Salvà F, Ros J, Saoudi N, García-Álvarez A, Hernando J, Capdevila J, Castells MR, Tabernero J, Élez E Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. García A, Comas R, Castillo G, Sanchis M Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Martí M, Espín E, Dopazo C Servei de Cirurgia General i Digestiva, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Landolfi S Servei d’Anatomia Patològica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Navalpotro B Servei d’Oncologia Radioteràpica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Guevara J Servei d’Aparell Digestiu, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Nuciforo P, Vivancos A Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: Translational Oncology;32; https://doi.org/10.1016/j.tranon.2023.101668Test; Baraibar I, García A, Salvà F, Ros J, Saoudi N, Comas R, et al. Impact of the COVID-19 pandemic in the early-onset colorectal cancer. Transl Oncol. 2023 Jun;32:101668.; https://hdl.handle.net/11351/9430Test; 000866211600326

  9. 9
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Baraibar I, Ros J, Saoudi N, Salvà F, Castells MR, Tabernero J, Élez E Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. García A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: ESMO Open;8(2); https://doi.org/10.1016/j.esmoop.2023.101204Test; Baraibar I, Ros J, Saoudi N, Salvà F, García A, Castells MR, et al. Sex and gender perspectives in colorectal cancer. ESMO Open. 2023 Apr;8(2):101204.; https://hdl.handle.net/11351/9426Test

  10. 10
    دورية أكاديمية

    المساهمون: Institut Català de la Salut, Ros J Department of Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy. Salva F, López D, Saoudi N, Baraibar I, Tabernero J, Elez E Department of Medical Oncology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Dopazo C, Charco R Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    العلاقة: British Journal of Cancer;128; https://doi.org/10.1038/s41416-023-02213-1Test; Ros J, Salva F, Dopazo C, López D, Saoudi N, Baraibar I, et al. Liver transplantation in metastatic colorectal cancer: are we ready for it? Br J Cancer. 2023 May;128:1797–806.; https://hdl.handle.net/11351/9826Test; 000943931600001